United States Transdermal Drug Patches Industry Market Analysis & Forecast 2018-2023
In the United States Transdermal Drug Patches Industry Market Analysis & Forecast 2018-2023, the revenue is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023. The production is estimated at XX million in 2017 and is forecasted to reach XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023.
It covers Regional Segment Analysis, Type, Appliction, Major Manufactures, Industry Chain Analysis, Competitive Insights and Macroeconomic Analysis.
The Major players reported in the market include:
Novartis
Boehringer Ingelheim
GlaxoSmithKline
Mylan
Noven
Bayer
Actavis
Echo Therapeutics
Teva Pharmaceuticals
United States Transdermal Drug PatchesMarket: Product Segment Analysis
Single-layer Drug-in-Adhesive
Multi-layer Drug-in-Adhesive
Others
United States Transdermal Drug PatchesMarket: Application Segment Analysis
Application 1
Application 2
Application 3
Reasons for Buying this Report
It covers Regional Segment Analysis, Type, Appliction, Major Manufactures, Industry Chain Analysis, Competitive Insights and Macroeconomic Analysis.
The Major players reported in the market include:
Novartis
Boehringer Ingelheim
GlaxoSmithKline
Mylan
Noven
Bayer
Actavis
Echo Therapeutics
Teva Pharmaceuticals
United States Transdermal Drug PatchesMarket: Product Segment Analysis
Single-layer Drug-in-Adhesive
Multi-layer Drug-in-Adhesive
Others
United States Transdermal Drug PatchesMarket: Application Segment Analysis
Application 1
Application 2
Application 3
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a six-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
United States Transdermal Drug Patches Industry Market Analysis & Forecast 2018-2023
CHAPTER 1 GLOBAL TRANSDERMAL DRUG PATCHESMARKET OVERVIEW
1.1 Product Overview and Scope of Global Transdermal Drug Patches Industry Market Analysis & Forecast 2018-2023
1.2 Global Transdermal Drug PatchesMarket Segmentation by Type
1.2.1 United States Production Market Share of Global Transdermal Drug Patchesby Type in 2016
1.2.1 Single-layer Drug-in-Adhesive
1.2.2 Multi-layer Drug-in-Adhesive
1.2.3 Others
1.3 Global Transdermal Drug PatchesMarket Segmentation by Application
1.3.1 Global Transdermal Drug PatchesConsumption Market Share by Application in 20156
1.3.2 Application
1.3.3 Application
1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Global Transdermal Drug Patches(2013-2023)
CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON GLOBAL TRANSDERMAL DRUG PATCHESINDUSTRY
2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend
CHAPTER 3 UNITED STATES TRANSDERMAL DRUG PATCHESMARKET COMPETITION BY MANUFACTURERS
3.1 United States Transdermal Drug PatchesProduction and Share by Manufacturers (2016 and 2017)
3.2 United States Transdermal Drug PatchesRevenue and Share by Manufacturers (2016 and 2017)
3.3 United States Transdermal Drug PatchesAverage Price by Manufacturers (2016 and 2017)
3.4 Manufacturers Global Transdermal Drug PatchesManufacturing Base Distribution, Production Area and Product Type
3.5 Global Transdermal Drug PatchesMarket Competitive Situation and Trends
3.5.1 Global Transdermal Drug PatchesMarket Concentration Rate
3.5.2 Global Transdermal Drug PatchesMarket Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
CHAPTER 4 UNITED STATES TRANSDERMAL DRUG PATCHESPRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 United States Transdermal Drug PatchesProduction and Market Share by Type (2013-2018)
4.2 United States Transdermal Drug PatchesRevenue and Market Share by Type (2013-2018)
4.3 United States Transdermal Drug PatchesPrice by Type (2013-2018)
4.4 United States Transdermal Drug PatchesProduction Growth by Type (2013-2018)
CHAPTER 5 UNITED STATES TRANSDERMAL DRUG PATCHESMARKET ANALYSIS BY APPLICATION
5.1 United States Transdermal Drug PatchesConsumption and Market Share by Application (2013-2018)
5.2 United States Transdermal Drug PatchesConsumption Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities
5.3.1 Potential Applications
5.3.2 Emerging Markets/Countries
CHAPTER 6 UNITED STATES TRANSDERMAL DRUG PATCHESMANUFACTURERS ANALYSIS
6.1 Novartis
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Product Type, Application and Specification
6.1.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Business Overview
6.2 Boehringer Ingelheim
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Product Type, Application and Specification
6.2.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Business Overview
6.3 GlaxoSmithKline
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Product Type, Application and Specification
6.3.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Business Overview
6.4 Mylan
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Product Type, Application and Specification
6.4.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Business Overview
6.5 Noven
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Product Type, Application and Specification
6.5.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Business Overview
6.6 Bayer
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Business Overview
6.7 Actavis
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Product Type, Application and Specification
6.7.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Business Overview
6.8 Echo Therapeutics
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Business Overview
6.9 Teva Pharmaceuticals
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Product Type, Application and Specification
6.9.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Business Overview
…
CHAPTER 7 GLOBAL TRANSDERMAL DRUG PATCHESMANUFACTURING COST ANALYSIS
7.1 Global Transdermal Drug PatchesKey Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Global Transdermal Drug Patches Industry Market Analysis & Forecast 2018-2023
CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Global Transdermal Drug PatchesIndustrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Global Transdermal Drug PatchesMajor Manufacturers in 2016
8.4 Downstream Buyers
CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
CHAPTER 11 UNITED STATES TRANSDERMAL DRUG PATCHESMARKET FORECAST (2018-2013)
11.1 United States Transdermal Drug PatchesProduction, Revenue Forecast (2018-2013)
11.2 United States Transdermal Drug PatchesProduction, Consumption Forecast by Regions (2018-2013)
11.3 United States Transdermal Drug PatchesProduction Forecast by Type (2018-2013)
11.4 United States Transdermal Drug PatchesConsumption Forecast by Application (2018-2013)
11.5 Global Transdermal Drug PatchesPrice Forecast (2018-2013)
CHAPTER 12 APPENDIX
CHAPTER 1 GLOBAL TRANSDERMAL DRUG PATCHESMARKET OVERVIEW
1.1 Product Overview and Scope of Global Transdermal Drug Patches Industry Market Analysis & Forecast 2018-2023
1.2 Global Transdermal Drug PatchesMarket Segmentation by Type
1.2.1 United States Production Market Share of Global Transdermal Drug Patchesby Type in 2016
1.2.1 Single-layer Drug-in-Adhesive
1.2.2 Multi-layer Drug-in-Adhesive
1.2.3 Others
1.3 Global Transdermal Drug PatchesMarket Segmentation by Application
1.3.1 Global Transdermal Drug PatchesConsumption Market Share by Application in 20156
1.3.2 Application
1.3.3 Application
1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Global Transdermal Drug Patches(2013-2023)
CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON GLOBAL TRANSDERMAL DRUG PATCHESINDUSTRY
2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend
CHAPTER 3 UNITED STATES TRANSDERMAL DRUG PATCHESMARKET COMPETITION BY MANUFACTURERS
3.1 United States Transdermal Drug PatchesProduction and Share by Manufacturers (2016 and 2017)
3.2 United States Transdermal Drug PatchesRevenue and Share by Manufacturers (2016 and 2017)
3.3 United States Transdermal Drug PatchesAverage Price by Manufacturers (2016 and 2017)
3.4 Manufacturers Global Transdermal Drug PatchesManufacturing Base Distribution, Production Area and Product Type
3.5 Global Transdermal Drug PatchesMarket Competitive Situation and Trends
3.5.1 Global Transdermal Drug PatchesMarket Concentration Rate
3.5.2 Global Transdermal Drug PatchesMarket Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
CHAPTER 4 UNITED STATES TRANSDERMAL DRUG PATCHESPRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 United States Transdermal Drug PatchesProduction and Market Share by Type (2013-2018)
4.2 United States Transdermal Drug PatchesRevenue and Market Share by Type (2013-2018)
4.3 United States Transdermal Drug PatchesPrice by Type (2013-2018)
4.4 United States Transdermal Drug PatchesProduction Growth by Type (2013-2018)
CHAPTER 5 UNITED STATES TRANSDERMAL DRUG PATCHESMARKET ANALYSIS BY APPLICATION
5.1 United States Transdermal Drug PatchesConsumption and Market Share by Application (2013-2018)
5.2 United States Transdermal Drug PatchesConsumption Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities
5.3.1 Potential Applications
5.3.2 Emerging Markets/Countries
CHAPTER 6 UNITED STATES TRANSDERMAL DRUG PATCHESMANUFACTURERS ANALYSIS
6.1 Novartis
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Product Type, Application and Specification
6.1.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Business Overview
6.2 Boehringer Ingelheim
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Product Type, Application and Specification
6.2.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Business Overview
6.3 GlaxoSmithKline
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Product Type, Application and Specification
6.3.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Business Overview
6.4 Mylan
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Product Type, Application and Specification
6.4.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Business Overview
6.5 Noven
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Product Type, Application and Specification
6.5.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Business Overview
6.6 Bayer
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Business Overview
6.7 Actavis
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Product Type, Application and Specification
6.7.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Business Overview
6.8 Echo Therapeutics
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Business Overview
6.9 Teva Pharmaceuticals
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Product Type, Application and Specification
6.9.3 Production, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Business Overview
…
CHAPTER 7 GLOBAL TRANSDERMAL DRUG PATCHESMANUFACTURING COST ANALYSIS
7.1 Global Transdermal Drug PatchesKey Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Global Transdermal Drug Patches Industry Market Analysis & Forecast 2018-2023
CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Global Transdermal Drug PatchesIndustrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Global Transdermal Drug PatchesMajor Manufacturers in 2016
8.4 Downstream Buyers
CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
CHAPTER 11 UNITED STATES TRANSDERMAL DRUG PATCHESMARKET FORECAST (2018-2013)
11.1 United States Transdermal Drug PatchesProduction, Revenue Forecast (2018-2013)
11.2 United States Transdermal Drug PatchesProduction, Consumption Forecast by Regions (2018-2013)
11.3 United States Transdermal Drug PatchesProduction Forecast by Type (2018-2013)
11.4 United States Transdermal Drug PatchesConsumption Forecast by Application (2018-2013)
11.5 Global Transdermal Drug PatchesPrice Forecast (2018-2013)
CHAPTER 12 APPENDIX
LIST OF TABLES AND FIGURES
Figure Picture of Global Transdermal Drug Patches Industry Market Analysis & Forecast 2018-2023
Table Classification of Global Transdermal Drug Patches Industry Market Analysis & Forecast 2018-2023
Figure United States Sales Market Share of Global Transdermal Drug Patchesby Type in 2016
Table Application of Global Transdermal Drug Patches Industry Market Analysis & Forecast 2018-2023
Figure United States Sales Market Share of Global Transdermal Drug Patchesby Application in 2016
Figure United States Transdermal Drug PatchesSales and Growth Rate (2013-2023)
Figure United States Transdermal Drug PatchesRevenue and Growth Rate (2013-2023)
Table United States Transdermal Drug PatchesSales of Key Manufacturers (2016 and 2017)
Table United States Transdermal Drug PatchesSales Share by Manufacturers (2016 and 2017)
Figure 2015 Global Transdermal Drug PatchesSales Share by Manufacturers
Figure 2016 Global Transdermal Drug PatchesSales Share by Manufacturers
Table United States Transdermal Drug PatchesRevenue by Manufacturers (2016 and 2017)
Table United States Transdermal Drug PatchesRevenue Share by Manufacturers (2016 and 2017)
Table 2015 United States Transdermal Drug PatchesRevenue Share by Manufacturers
Table 2016 United States Transdermal Drug PatchesRevenue Share by Manufacturers
Table United States Market Global Transdermal Drug PatchesAverage Price of Key Manufacturers (2016 and 2017)
Figure United States Market Global Transdermal Drug PatchesAverage Price of Key Manufacturers in 2016
Figure Global Transdermal Drug PatchesMarket Share of Top 3 Manufacturers
Figure Global Transdermal Drug PatchesMarket Share of Top 5 Manufacturers
Table United States Transdermal Drug PatchesSales by Type (2013-2018)
Table United States Transdermal Drug PatchesSales Share by Type (2013-2018)
Figure United States Transdermal Drug PatchesSales Market Share by Type in 2016
Table United States Transdermal Drug PatchesRevenue and Market Share by Type (2013-2018)
Table United States Transdermal Drug PatchesRevenue Share by Type (2013-2018)
Figure Revenue Market Share of Global Transdermal Drug Patchesby Type (2013-2018)
Table United States Transdermal Drug PatchesPrice by Type (2013-2018)
Figure United States Transdermal Drug PatchesSales Growth Rate by Type (2013-2018)
Table United States Transdermal Drug PatchesSales by Application (2013-2018)
Table United States Transdermal Drug PatchesSales Market Share by Application (2013-2018)
Figure United States Transdermal Drug PatchesSales Market Share by Application in 2015
Table United States Transdermal Drug PatchesSales Growth Rate by Application (2013-2018)
Figure United States Transdermal Drug PatchesSales Growth Rate by Application (2013-2018)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Global Transdermal Drug PatchesProduction, Revenue, Price and Gross Margin (2013-2018)
Table Novartis Global Transdermal Drug PatchesMarket Share (2013-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Boehringer Ingelheim Global Transdermal Drug PatchesProduction, Revenue, Price and Gross Margin (2013-2018)
Table Boehringer Ingelheim Global Transdermal Drug PatchesMarket Share (2013-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Global Transdermal Drug PatchesProduction, Revenue, Price and Gross Margin (2013-2018)
Table GlaxoSmithKline Global Transdermal Drug PatchesMarket Share (2013-2018)
Table Mylan Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Mylan Global Transdermal Drug PatchesProduction, Revenue, Price and Gross Margin (2013-2018)
Table Mylan Global Transdermal Drug PatchesMarket Share (2013-2018)
Table Noven Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Noven Global Transdermal Drug PatchesProduction, Revenue, Price and Gross Margin (2013-2018)
Table Noven Global Transdermal Drug PatchesMarket Share (2013-2018)
Table Bayer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bayer Global Transdermal Drug PatchesProduction, Revenue, Price and Gross Margin (2013-2018)
Table Bayer Global Transdermal Drug PatchesMarket Share (2013-2018)
Table Actavis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Actavis Global Transdermal Drug PatchesProduction, Revenue, Price and Gross Margin (2013-2018)
Table Actavis Global Transdermal Drug PatchesMarket Share (2013-2018)
Table Echo Therapeutics Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Echo Therapeutics Global Transdermal Drug PatchesProduction, Revenue, Price and Gross Margin (2013-2018)
Table Echo Therapeutics Global Transdermal Drug PatchesMarket Share (2013-2018)
Table Teva Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Teva Pharmaceuticals Global Transdermal Drug PatchesProduction, Revenue, Price and Gross Margin (2013-2018)
Table Teva Pharmaceuticals Global Transdermal Drug PatchesMarket Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Global Transdermal Drug Patches Industry Market Analysis & Forecast 2018-2023
Figure Manufacturing Process Analysis of Global Transdermal Drug Patches Industry Market Analysis & Forecast 2018-2023
Figure Global Transdermal Drug PatchesIndustrial Chain Analysis
Table Raw Materials Sources of Global Transdermal Drug PatchesMajor Manufacturers in 2016
Table Major Buyers of Global Transdermal Drug Patches Industry Market Analysis & Forecast 2018-2023
Table Distributors/Traders List
Figure United States Transdermal Drug PatchesProduction and Growth Rate Forecast (2018-2013)
Figure United States Transdermal Drug PatchesRevenue and Growth Rate Forecast (2018-2013)
Table United States Transdermal Drug PatchesProduction Forecast by Type (2018-2013)
Table United States Transdermal Drug PatchesConsumption Forecast by Application (2018-2013)
COMPANIES MENTIONED
Novartis Boehringer Ingelheim GlaxoSmithKline Mylan Noven Bayer Actavis Echo Therapeutics Teva Pharmaceuticals
Figure Picture of Global Transdermal Drug Patches Industry Market Analysis & Forecast 2018-2023
Table Classification of Global Transdermal Drug Patches Industry Market Analysis & Forecast 2018-2023
Figure United States Sales Market Share of Global Transdermal Drug Patchesby Type in 2016
Table Application of Global Transdermal Drug Patches Industry Market Analysis & Forecast 2018-2023
Figure United States Sales Market Share of Global Transdermal Drug Patchesby Application in 2016
Figure United States Transdermal Drug PatchesSales and Growth Rate (2013-2023)
Figure United States Transdermal Drug PatchesRevenue and Growth Rate (2013-2023)
Table United States Transdermal Drug PatchesSales of Key Manufacturers (2016 and 2017)
Table United States Transdermal Drug PatchesSales Share by Manufacturers (2016 and 2017)
Figure 2015 Global Transdermal Drug PatchesSales Share by Manufacturers
Figure 2016 Global Transdermal Drug PatchesSales Share by Manufacturers
Table United States Transdermal Drug PatchesRevenue by Manufacturers (2016 and 2017)
Table United States Transdermal Drug PatchesRevenue Share by Manufacturers (2016 and 2017)
Table 2015 United States Transdermal Drug PatchesRevenue Share by Manufacturers
Table 2016 United States Transdermal Drug PatchesRevenue Share by Manufacturers
Table United States Market Global Transdermal Drug PatchesAverage Price of Key Manufacturers (2016 and 2017)
Figure United States Market Global Transdermal Drug PatchesAverage Price of Key Manufacturers in 2016
Figure Global Transdermal Drug PatchesMarket Share of Top 3 Manufacturers
Figure Global Transdermal Drug PatchesMarket Share of Top 5 Manufacturers
Table United States Transdermal Drug PatchesSales by Type (2013-2018)
Table United States Transdermal Drug PatchesSales Share by Type (2013-2018)
Figure United States Transdermal Drug PatchesSales Market Share by Type in 2016
Table United States Transdermal Drug PatchesRevenue and Market Share by Type (2013-2018)
Table United States Transdermal Drug PatchesRevenue Share by Type (2013-2018)
Figure Revenue Market Share of Global Transdermal Drug Patchesby Type (2013-2018)
Table United States Transdermal Drug PatchesPrice by Type (2013-2018)
Figure United States Transdermal Drug PatchesSales Growth Rate by Type (2013-2018)
Table United States Transdermal Drug PatchesSales by Application (2013-2018)
Table United States Transdermal Drug PatchesSales Market Share by Application (2013-2018)
Figure United States Transdermal Drug PatchesSales Market Share by Application in 2015
Table United States Transdermal Drug PatchesSales Growth Rate by Application (2013-2018)
Figure United States Transdermal Drug PatchesSales Growth Rate by Application (2013-2018)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Global Transdermal Drug PatchesProduction, Revenue, Price and Gross Margin (2013-2018)
Table Novartis Global Transdermal Drug PatchesMarket Share (2013-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Boehringer Ingelheim Global Transdermal Drug PatchesProduction, Revenue, Price and Gross Margin (2013-2018)
Table Boehringer Ingelheim Global Transdermal Drug PatchesMarket Share (2013-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Global Transdermal Drug PatchesProduction, Revenue, Price and Gross Margin (2013-2018)
Table GlaxoSmithKline Global Transdermal Drug PatchesMarket Share (2013-2018)
Table Mylan Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Mylan Global Transdermal Drug PatchesProduction, Revenue, Price and Gross Margin (2013-2018)
Table Mylan Global Transdermal Drug PatchesMarket Share (2013-2018)
Table Noven Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Noven Global Transdermal Drug PatchesProduction, Revenue, Price and Gross Margin (2013-2018)
Table Noven Global Transdermal Drug PatchesMarket Share (2013-2018)
Table Bayer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bayer Global Transdermal Drug PatchesProduction, Revenue, Price and Gross Margin (2013-2018)
Table Bayer Global Transdermal Drug PatchesMarket Share (2013-2018)
Table Actavis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Actavis Global Transdermal Drug PatchesProduction, Revenue, Price and Gross Margin (2013-2018)
Table Actavis Global Transdermal Drug PatchesMarket Share (2013-2018)
Table Echo Therapeutics Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Echo Therapeutics Global Transdermal Drug PatchesProduction, Revenue, Price and Gross Margin (2013-2018)
Table Echo Therapeutics Global Transdermal Drug PatchesMarket Share (2013-2018)
Table Teva Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Teva Pharmaceuticals Global Transdermal Drug PatchesProduction, Revenue, Price and Gross Margin (2013-2018)
Table Teva Pharmaceuticals Global Transdermal Drug PatchesMarket Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Global Transdermal Drug Patches Industry Market Analysis & Forecast 2018-2023
Figure Manufacturing Process Analysis of Global Transdermal Drug Patches Industry Market Analysis & Forecast 2018-2023
Figure Global Transdermal Drug PatchesIndustrial Chain Analysis
Table Raw Materials Sources of Global Transdermal Drug PatchesMajor Manufacturers in 2016
Table Major Buyers of Global Transdermal Drug Patches Industry Market Analysis & Forecast 2018-2023
Table Distributors/Traders List
Figure United States Transdermal Drug PatchesProduction and Growth Rate Forecast (2018-2013)
Figure United States Transdermal Drug PatchesRevenue and Growth Rate Forecast (2018-2013)
Table United States Transdermal Drug PatchesProduction Forecast by Type (2018-2013)
Table United States Transdermal Drug PatchesConsumption Forecast by Application (2018-2013)
COMPANIES MENTIONED
Novartis Boehringer Ingelheim GlaxoSmithKline Mylan Noven Bayer Actavis Echo Therapeutics Teva Pharmaceuticals
